首页 > 最新文献

Vestnik oftalmologii最新文献

英文 中文
[Ocular myasthenia gravis]. [眼肌萎缩症]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414004186
M S Sergeeva, S S Danilov, N I Sherbakova

Myasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as intermittent ptosis of the upper eyelid and/or binocular diplopia. In 15% of cases, clinical manifestations are limited to impairment of the levator palpebrae superioris and extraocular muscles, characteristic of the ocular form of myasthenia gravis. Specialists often encounter challenges in diagnosing this form, as serological and electrophysiological studies may be uninformative, necessitating diagnosis based on patient history and clinical picture. This literature review outlines the key aspects of the pathogenesis, clinical manifestations, methods of diagnosis and treatment of ocular myasthenia gravis.

重症肌无力是一种自身免疫性疾病,其特征是肌肉无力和病理性疲劳,这是由于针对神经肌肉突触的各种结构形成抗体的自身攻击现象所致。在大多数患者中,该病首先累及眼外肌,表现为上眼睑间歇性下垂和/或双眼复视等症状。在 15%的病例中,临床表现仅限于上睑提肌和眼外肌受损,这是眼肌型重症肌无力的特征。专科医生在诊断眼肌型重症肌无力时经常会遇到困难,因为血清学和电生理学研究可能无法提供信息,因此必须根据患者的病史和临床表现进行诊断。这篇文献综述概述了眼肌型重症肌无力症的发病机制、临床表现、诊断方法和治疗等主要方面。
{"title":"[Ocular myasthenia gravis].","authors":"M S Sergeeva, S S Danilov, N I Sherbakova","doi":"10.17116/oftalma202414004186","DOIUrl":"https://doi.org/10.17116/oftalma202414004186","url":null,"abstract":"<p><p>Myasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as intermittent ptosis of the upper eyelid and/or binocular diplopia. In 15% of cases, clinical manifestations are limited to impairment of the levator palpebrae superioris and extraocular muscles, characteristic of the ocular form of myasthenia gravis. Specialists often encounter challenges in diagnosing this form, as serological and electrophysiological studies may be uninformative, necessitating diagnosis based on patient history and clinical picture. This literature review outlines the key aspects of the pathogenesis, clinical manifestations, methods of diagnosis and treatment of ocular myasthenia gravis.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 4","pages":"86-91"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The effect of pleoptic treatment on the stability of visual fixation in children and adolescents with amblyopia of various degrees]. [对不同程度弱视的儿童和青少年进行多视点治疗对视觉固定稳定性的影响]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414001132
M A Kashchenko, T P Kashchenko, M D Magaramova, E K Pedanova, S E Golyakhovskiy

Purpose: This study assesses the effect of pleoptic treatment on the stability of visual fixation in children and adolescents with amblyopia of various degrees.

Material and methods: The effect of the treatment in 35 children (35 eyes) with amblyopia of various degrees was evaluated using the MP-1 Microperimeter. The stability was determined by two criteria - number of fixation point hits in the 2° zone and the width of the field of fixation. Children underwent a standard course of treatment.

Results: There was an improvement in the stability of visual fixation after treatment. The number of fixation point hits in the 2° zone increased from 44.8±4.1% to 52.6±3.8%. At the same time, the width of the field of fixation after treatment decreased from 6.5±0.7° to 5.2±0.5°. Visual acuity with correction in children with amblyopia correlates with the number of fixation point hits in the 2° zone (direct high correlation "+0.7") and width of the field of fixation (inverse high correlation "-0.7") both before and after the treatment.

Conclusion: Stabilization of visual fixation was observed in patients with amblyopia of varying degrees after the pleoptic treatment.

目的:本研究评估了褶皱治疗对不同程度弱视的儿童和青少年视觉固定稳定性的影响:使用MP-1显微镜评估了35名不同程度弱视儿童(35只眼)的治疗效果。稳定性由两个标准决定--2°区域内的定点命中数和定点视野的宽度。患儿接受了标准疗程的治疗:结果:治疗后,视觉固定的稳定性有所改善。2°区域的固定点命中率从44.8±4.1%增至52.6±3.8%。同时,治疗后固视区的宽度从 6.5±0.7° 降至 5.2±0.5°。弱视儿童矫正后的视力与治疗前后2°区域内的固定点命中数(直接高度相关 "+0.7")和固定视野宽度(反向高度相关"-0.7")相关:结论:不同程度的弱视患者在接受褶视治疗后,视觉定点均趋于稳定。
{"title":"[The effect of pleoptic treatment on the stability of visual fixation in children and adolescents with amblyopia of various degrees].","authors":"M A Kashchenko, T P Kashchenko, M D Magaramova, E K Pedanova, S E Golyakhovskiy","doi":"10.17116/oftalma202414001132","DOIUrl":"10.17116/oftalma202414001132","url":null,"abstract":"<p><strong>Purpose: </strong>This study assesses the effect of pleoptic treatment on the stability of visual fixation in children and adolescents with amblyopia of various degrees.</p><p><strong>Material and methods: </strong>The effect of the treatment in 35 children (35 eyes) with amblyopia of various degrees was evaluated using the MP-1 Microperimeter. The stability was determined by two criteria - number of fixation point hits in the 2° zone and the width of the field of fixation. Children underwent a standard course of treatment.</p><p><strong>Results: </strong>There was an improvement in the stability of visual fixation after treatment. The number of fixation point hits in the 2° zone increased from 44.8±4.1% to 52.6±3.8%. At the same time, the width of the field of fixation after treatment decreased from 6.5±0.7° to 5.2±0.5°. Visual acuity with correction in children with amblyopia correlates with the number of fixation point hits in the 2° zone (direct high correlation \"+0.7\") and width of the field of fixation (inverse high correlation \"-0.7\") both before and after the treatment.</p><p><strong>Conclusion: </strong>Stabilization of visual fixation was observed in patients with amblyopia of varying degrees after the pleoptic treatment.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 1","pages":"32-35"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The first experience of using femtosecond laser in the treatment of anterior capsular contraction syndrome]. [使用飞秒激光治疗前囊收缩综合征的首次经验]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414001165
Yu N Yusef, S N Yusef, A S Vvedenskiy, A A Gamidov, M N Ivanov, K S Avetisov, K Alkhumidi

Prevention and treatment of anterior capsular contraction syndrome (ACCS) is a relevant problem in cataract surgery.

Purpose: The study was performed to develop a femtosecond laser-assisted technique for anterior capsulotomy in anterior capsular contraction syndrome and assess its preliminary results in preventing the progression of pathological changes in the capsular bag.

Material and methods: The examination and femtosecond laser-assisted treatment without additional surgical intervention was performed in 6 patients (6 eyes) aged 69 to 73 years with anterior capsular contraction syndrome. Femtosecond laser-assisted anterior capsulotomy was performed using the VICTUS system (Technolas Perfect Vision, Germany). Capsulotomy diameter was 4.0-4.5 mm, laser radiation energy - 9000 nJ, laser exposure depth 900-1000 μm.

Results: The diameter of the anterior capsulotomy before treatment was 2.85 mm [2.75; 2.93]. After 1 month, the diameter of the anterior capsular opening was 2.88 mm [2.78; 2.96] (p>0.05). One year after femtosecond laser intervention, the anterior capsulotomy opening was almost the same shape and diameter - 2.84 mm [2.74; 2.94] (p>0.05).

Conclusion: Femtosecond laser-assisted circular capsulotomy is an effective and safe method for preventing the progression of anterior capsular contraction syndrome in the absence of severe IOL decentration and for maintaining the diameter of the anterior capsular opening of at least 2.5-3.0 mm.

目的:该研究旨在开发一种飞秒激光辅助的前囊切开术治疗前囊收缩综合征,并评估其在防止囊袋病理变化进展方面的初步效果:对6名年龄在69至73岁之间的前囊收缩综合征患者(6只眼)进行了检查和飞秒激光辅助治疗,无额外手术干预。飞秒激光辅助前囊切开术是使用 VICTUS 系统(德国 Technolas Perfect Vision 公司)进行的。囊肿切除直径为 4.0-4.5 mm,激光辐射能量为 9000 nJ,激光照射深度为 900-1000 μm:结果:治疗前的前囊切直径为 2.85 mm [2.75; 2.93]。一个月后,前囊口直径为 2.88 mm [2.78; 2.96] (p>0.05)。飞秒激光介入治疗一年后,前囊开口的形状和直径几乎保持不变--2.84 毫米 [2.74; 2.94] (P>0.05):飞秒激光辅助环形囊切开术是一种有效、安全的方法,可在无严重人工晶体脱位的情况下防止前囊收缩综合征的发展,并将前囊开口直径维持在至少2.5-3.0毫米。
{"title":"[The first experience of using femtosecond laser in the treatment of anterior capsular contraction syndrome].","authors":"Yu N Yusef, S N Yusef, A S Vvedenskiy, A A Gamidov, M N Ivanov, K S Avetisov, K Alkhumidi","doi":"10.17116/oftalma202414001165","DOIUrl":"10.17116/oftalma202414001165","url":null,"abstract":"<p><p>Prevention and treatment of anterior capsular contraction syndrome (ACCS) is a relevant problem in cataract surgery.</p><p><strong>Purpose: </strong>The study was performed to develop a femtosecond laser-assisted technique for anterior capsulotomy in anterior capsular contraction syndrome and assess its preliminary results in preventing the progression of pathological changes in the capsular bag.</p><p><strong>Material and methods: </strong>The examination and femtosecond laser-assisted treatment without additional surgical intervention was performed in 6 patients (6 eyes) aged 69 to 73 years with anterior capsular contraction syndrome. Femtosecond laser-assisted anterior capsulotomy was performed using the VICTUS system (Technolas Perfect Vision, Germany). Capsulotomy diameter was 4.0-4.5 mm, laser radiation energy - 9000 nJ, laser exposure depth 900-1000 μm.</p><p><strong>Results: </strong>The diameter of the anterior capsulotomy before treatment was 2.85 mm [2.75; 2.93]. After 1 month, the diameter of the anterior capsular opening was 2.88 mm [2.78; 2.96] (<i>p</i>>0.05). One year after femtosecond laser intervention, the anterior capsulotomy opening was almost the same shape and diameter - 2.84 mm [2.74; 2.94] (<i>p</i>>0.05).</p><p><strong>Conclusion: </strong>Femtosecond laser-assisted circular capsulotomy is an effective and safe method for preventing the progression of anterior capsular contraction syndrome in the absence of severe IOL decentration and for maintaining the diameter of the anterior capsular opening of at least 2.5-3.0 mm.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 1","pages":"65-70"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[New possibilities for reparative therapy of dry eye syndrome]. [干眼症修复疗法的新可能性]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414001158
V V Brzheskiy, E A Drozdova, V A Bobryshev, E V Berdnikova, S Yu Golubev

In recent years, among artificial tear preparations that have additional metabolic properties, in addition to moisturizing the ocular surface, there has been a drug Optinol Soft Recovery (LLC JADRAN). In addition to 0.15% sodium hyaluronate, it contains 2% dexpanthenol, which stimulates reparative regeneration of the corneal epithelium, in particular in patients with dry eye syndrome (DES).

Purpose: This study evaluates the clinical efficacy of the drug Optinol Soft Recovery in the treatment of patients with DES accompanied by xerotic changes in the corneal epithelium.

Material and methods: The study included 82 patients (15 children and 65 adults) with moderate and severe DES accompanied by the following corneal pathology: filamentous keratitis (20 patients, 33 eyes), persistent corneal erosion (28 patients, 49 eyes) and punctate keratopathy (34 patients, 68 eyes).

Results: All patients receiving fourfold instillations of the studied drug were observed already during the first 7 days to have increased stability of the tear film and decreased severity of staining of the cornea and conjunctiva with vital dyes (0.1% sodium fluorescein and 3% lissamine green, respectively). Further, as the patients were transferred to an individual instillation regimen, a progressive decrease in the Ocular Surface Disease Index (OSDI), an increase in corneal sensitivity and tear meniscus index were also recorded. The differences in most parameters of the course of xerosis compared to the initial ones were statistically significant starting from day 10-20 of therapy, depending on the initial severity of corneal xerosis (p<0.05-0.001).

Conclusion: Patients with moderate DES complicated by punctate keratopathy were the most susceptible to therapy with the drug Optinol Soft Recovery, while patients with filamentous keratitis secondary to a severe clinical form of DES were the least susceptible.

近年来,在具有额外代谢特性的人工泪液制剂中,除了滋润眼表之外,还有一种药物 Optinol Soft Recovery(LLC JADRAN)。除了 0.15%的透明质酸钠外,它还含有 2%dexpanthenol,能刺激角膜上皮的修复性再生,尤其适用于干眼症(DES)患者。目的:本研究评估了 Optinol Soft Recovery 药物在治疗伴有角膜上皮干燥性变化的 DES 患者中的临床疗效:研究对象包括82名患有中度和重度DES并伴有以下角膜病变的患者(15名儿童和65名成人):丝状角膜炎(20名患者,33只眼)、持续性角膜糜烂(28名患者,49只眼)和点状角膜病(34名患者,68只眼):所有接受四倍剂量药物注射的患者在最初的 7 天内都能观察到泪膜的稳定性增强,角膜和结膜被重要染料(分别为 0.1%荧光素钠和 3%立沙明绿)染色的严重程度降低。此外,随着患者转为个体化灌注方案,眼表疾病指数(OSDI)逐渐下降,角膜敏感度和泪液半月板指数也有所上升。根据角膜角化病的最初严重程度,从治疗的第 10-20 天开始,大部分角化病病程参数与最初参数相比都有显著的统计学差异(p 结论:中度 DES 并发点状角膜病变的患者最容易接受 Optinol Soft Recovery 药物治疗,而继发于严重临床形式 DES 的丝状角膜炎患者最不容易接受。
{"title":"[New possibilities for reparative therapy of dry eye syndrome].","authors":"V V Brzheskiy, E A Drozdova, V A Bobryshev, E V Berdnikova, S Yu Golubev","doi":"10.17116/oftalma202414001158","DOIUrl":"10.17116/oftalma202414001158","url":null,"abstract":"<p><p>In recent years, among artificial tear preparations that have additional metabolic properties, in addition to moisturizing the ocular surface, there has been a drug Optinol Soft Recovery (LLC JADRAN). In addition to 0.15% sodium hyaluronate, it contains 2% dexpanthenol, which stimulates reparative regeneration of the corneal epithelium, in particular in patients with dry eye syndrome (DES).</p><p><strong>Purpose: </strong>This study evaluates the clinical efficacy of the drug Optinol Soft Recovery in the treatment of patients with DES accompanied by xerotic changes in the corneal epithelium.</p><p><strong>Material and methods: </strong>The study included 82 patients (15 children and 65 adults) with moderate and severe DES accompanied by the following corneal pathology: filamentous keratitis (20 patients, 33 eyes), persistent corneal erosion (28 patients, 49 eyes) and punctate keratopathy (34 patients, 68 eyes).</p><p><strong>Results: </strong>All patients receiving fourfold instillations of the studied drug were observed already during the first 7 days to have increased stability of the tear film and decreased severity of staining of the cornea and conjunctiva with vital dyes (0.1% sodium fluorescein and 3% lissamine green, respectively). Further, as the patients were transferred to an individual instillation regimen, a progressive decrease in the Ocular Surface Disease Index (OSDI), an increase in corneal sensitivity and tear meniscus index were also recorded. The differences in most parameters of the course of xerosis compared to the initial ones were statistically significant starting from day 10-20 of therapy, depending on the initial severity of corneal xerosis (<i>p</i><0.05-0.001).</p><p><strong>Conclusion: </strong>Patients with moderate DES complicated by punctate keratopathy were the most susceptible to therapy with the drug Optinol Soft Recovery, while patients with filamentous keratitis secondary to a severe clinical form of DES were the least susceptible.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 1","pages":"58-64"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current capabilities of anterior segment optical coherence tomography]. [前段光学相干断层扫描的当前功能]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma2024140022190
L Alkharki, Yu N Yusef, M V Budzinskaya, K S Avetisov, A V Shitikova

Optical coherence tomography of the anterior segment of the eye (AS-OCT) is a non-invasive method based on the principles of optical reflectometry (measurement of the degree of backscattering of light passing through transparent or translucent media). Limitations of the first devices of this type were associated with insufficient image quality of the details of the anterior chamber angle and the posterior parts of the lens, primarily due to the "working" level of the scanning wavelength (within 800 μm). Fundamentally new possibilities in the structural and functional assessment of the anterior segment of the eye are associated with the introduction into clinical practice of swept-source AS-OCT device - the CASIA2 anterior optical coherence tomograph (Tomey Corporation, Japan). Its high scanning speed (50 000 A-scans per second) with a wavelength of 1310 μm allows high-quality visualization by building a scan at a depth of 13 mm. The previous model (CASIA SS-1000, Tomey Corporation, Japan) supported scan depth of only 6 mm. This review summarizes the results of research on the clinical use of CASIA2 tomograph.

眼球前段光学相干断层扫描(AS-OCT)是一种基于光学反射测量原理的无创方法(测量光线通过透明或半透明介质时的反向散射程度)。首批此类设备的局限性与前房角和晶状体后部细节的图像质量不足有关,这主要是由于扫描波长的 "工作 "水平(800 微米以内)造成的。扫源 AS-OCT 设备--CASIA2 前部光学相干断层成像仪(日本 Tomey 公司)被引入临床实践,从根本上为眼球前段的结构和功能评估提供了新的可能性。它的扫描速度快(每秒可扫描 50 000 次),波长为 1310 μm,可在 13 毫米的深度进行扫描,从而实现高质量的视觉效果。以前的型号(CASIA SS-1000,日本东美公司)仅支持 6 毫米的扫描深度。本综述总结了 CASIA2 层析成像仪的临床应用研究成果。
{"title":"[Current capabilities of anterior segment optical coherence tomography].","authors":"L Alkharki, Yu N Yusef, M V Budzinskaya, K S Avetisov, A V Shitikova","doi":"10.17116/oftalma2024140022190","DOIUrl":"10.17116/oftalma2024140022190","url":null,"abstract":"<p><p>Optical coherence tomography of the anterior segment of the eye (AS-OCT) is a non-invasive method based on the principles of optical reflectometry (measurement of the degree of backscattering of light passing through transparent or translucent media). Limitations of the first devices of this type were associated with insufficient image quality of the details of the anterior chamber angle and the posterior parts of the lens, primarily due to the \"working\" level of the scanning wavelength (within 800 μm). Fundamentally new possibilities in the structural and functional assessment of the anterior segment of the eye are associated with the introduction into clinical practice of swept-source AS-OCT device - the CASIA2 anterior optical coherence tomograph (Tomey Corporation, Japan). Its high scanning speed (50 000 A-scans per second) with a wavelength of 1310 μm allows high-quality visualization by building a scan at a depth of 13 mm. The previous model (CASIA SS-1000, Tomey Corporation, Japan) supported scan depth of only 6 mm. This review summarizes the results of research on the clinical use of CASIA2 tomograph.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 2. Vyp. 2","pages":"190-195"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140912804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epigenetic markers of choroidal melanoma]. [脉络膜黑色素瘤的表观遗传标记]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma20241400315
A F Brovkina, N D Tsybikova

MicroRNAs (miRNAs) are short non-coding RNAs (18-25 nucleotides in length) that are important participants in the regulation of gene expression. In 2003, their active role in oncogenesis was demonstrated. In 2008, the first report on the isolation of miRNAs from uveal melanoma (UM) tissue was published. Four years later (2012), the presence of miRNAs in the plasma of patients with this category was shown. To date, changes in the expression level of 100 miRNAs in the plasma of cancer patients (with cancer of various localizations) out of the 2654 miRNAs described in mirbase.org have been proven. In the plasma of patients with UM, changes in the expression of only 13 miRNAs have been confirmed. As a rule, studies were conducted in patients at the stage of hematogenous metastasis of UM.

Purpose: This study analyzed the expression pattern of miRNA-223 and miRNA-126 in patients with localized choroidal melanoma (CM) taking into account biometric parameters in the absence of metastases.

Material and methods: Blood plasma of 84 patients with M0N0 CM aged 35-86 years (mean age 63.4±1.2 years) was investigated. The basis for the diagnosis of CM was the results of ophthalmological examination, optical coherence tomography, and ultrasound scanning. In all cases, the absence of metastases was proven (using computed tomography or magnetic resonance imaging). Control - plasma of 28 volunteers (mean age 62.9±1.42 years, age range 45-78 years), who did not have tumoral, autoimmune, or chronic inflammatory processes. The expression levels of miRNAs circulating in blood plasma were determined by real-time polymerase chain reaction.

Results: An increase in the expression levels of miRNA-223 and miRNA-126 in the plasma of all 84 patients with CM was confirmed compared to the control group. Features of the miRNA expression pattern that emerged with changes in the tumor's quantitative parameters were identified.

Conclusion: Evaluation of the levels of miRNA-223 and miRNA-126 in the blood plasma of patients with CM can be used in clinical practice to clarify the diagnosis of CM, as well as to predict the development of hematogenous metastases.

微小核糖核酸(miRNA)是一种短的非编码核糖核酸(长度为 18-25 个核苷酸),是基因表达调控的重要参与者。2003 年,它们在肿瘤发生中的积极作用得到证实。2008 年,首次发表了从葡萄膜黑色素瘤(UM)组织中分离 miRNA 的报告。四年后(2012 年),研究显示该类患者的血浆中存在 miRNA。迄今为止,mirbase.org 上描述的 2654 个 miRNA 中,已有 100 个 miRNA 在癌症患者(不同部位的癌症)血浆中的表达水平发生了变化。在 UM 患者的血浆中,只有 13 个 miRNA 的表达变化得到证实。目的:本研究分析了局部脉络膜黑色素瘤(CM)患者体内 miRNA-223 和 miRNA-126 的表达模式,同时考虑了无转移情况下的生物计量学参数:调查了 84 名年龄在 35-86 岁(平均年龄为 63.4±1.2 岁)的 M0N0 CM 患者的血浆。诊断 CM 的依据是眼科检查、光学相干断层扫描和超声波扫描的结果。所有病例均证明没有转移(使用计算机断层扫描或磁共振成像)。对照组--28 名志愿者(平均年龄(62.9±1.42)岁,年龄范围 45-78 岁)的血浆,他们没有肿瘤、自身免疫或慢性炎症过程。通过实时聚合酶链反应测定血浆中循环 miRNA 的表达水平:结果:与对照组相比,84 例 CM 患者血浆中 miRNA-223 和 miRNA-126 的表达水平均有所升高。结果:与对照组相比,84 例 CM 患者血浆中 miRNA-223 和 miRNA-126 的表达水平均有所增加:结论:对CM患者血浆中miRNA-223和miRNA-126水平的评估可用于临床实践,以明确CM的诊断,并预测血行转移的发生。
{"title":"[Epigenetic markers of choroidal melanoma].","authors":"A F Brovkina, N D Tsybikova","doi":"10.17116/oftalma20241400315","DOIUrl":"https://doi.org/10.17116/oftalma20241400315","url":null,"abstract":"<p><p>MicroRNAs (miRNAs) are short non-coding RNAs (18-25 nucleotides in length) that are important participants in the regulation of gene expression. In 2003, their active role in oncogenesis was demonstrated. In 2008, the first report on the isolation of miRNAs from uveal melanoma (UM) tissue was published. Four years later (2012), the presence of miRNAs in the plasma of patients with this category was shown. To date, changes in the expression level of 100 miRNAs in the plasma of cancer patients (with cancer of various localizations) out of the 2654 miRNAs described in mirbase.org have been proven. In the plasma of patients with UM, changes in the expression of only 13 miRNAs have been confirmed. As a rule, studies were conducted in patients at the stage of hematogenous metastasis of UM.</p><p><strong>Purpose: </strong>This study analyzed the expression pattern of miRNA-223 and miRNA-126 in patients with localized choroidal melanoma (CM) taking into account biometric parameters in the absence of metastases.</p><p><strong>Material and methods: </strong>Blood plasma of 84 patients with M<sub>0</sub>N<sub>0</sub> CM aged 35-86 years (mean age 63.4±1.2 years) was investigated. The basis for the diagnosis of CM was the results of ophthalmological examination, optical coherence tomography, and ultrasound scanning. In all cases, the absence of metastases was proven (using computed tomography or magnetic resonance imaging). Control - plasma of 28 volunteers (mean age 62.9±1.42 years, age range 45-78 years), who did not have tumoral, autoimmune, or chronic inflammatory processes. The expression levels of miRNAs circulating in blood plasma were determined by real-time polymerase chain reaction.</p><p><strong>Results: </strong>An increase in the expression levels of miRNA-223 and miRNA-126 in the plasma of all 84 patients with CM was confirmed compared to the control group. Features of the miRNA expression pattern that emerged with changes in the tumor's quantitative parameters were identified.</p><p><strong>Conclusion: </strong>Evaluation of the levels of miRNA-223 and miRNA-126 in the blood plasma of patients with CM can be used in clinical practice to clarify the diagnosis of CM, as well as to predict the development of hematogenous metastases.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"5-10"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Three-component tear substitute as preoperative support in glaucoma surgery]. [三组分泪液替代物作为青光眼手术的术前支持]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414003151
N V Makashova, A E Vasillyeva, O Yu Kolosova

Purpose: This study investigates the effect of preoperative preparation with the three-component tear substitute Stillavit on the outcomes of glaucoma surgery in patients on long-term topical glaucoma therapy.

Material and methods: The study included 63 patients (63 eyes) with glaucoma, among them 30 (30 eyes) were women and 33 (33 eyes) were men. Group 1 consisted of 33 patients (33 eyes) receiving long-term topical antihypertensive therapy with preservatives and tear substitute Stillavit 3 times a day for 1 month as preoperative preparation. Group 2 included 30 patients (30 eyes) receiving similar antihypertensive therapy who were not prescribed preoperative medications. All patients underwent a comprehensive ophthalmological examination and computer tomography of the filtering blebs (FB) on Visante system (Carl Zeiss Meditec, Germany) before surgery, as well as 1 week, 1, 3, and 6 months after surgery.

Results: Mean intraocular pressure (IOP) elevation at 6 months postoperatively was significantly higher in the group that did not undergo preoperative preparation with a tear substitute, compared to the group of patients who received the tear substitute Stillavit preoperatively. According to anterior segment optical coherence tomography, a greater number of favorable diffuse FB were noted in the group that received the tear substitute Stillavit in preparation for surgery - 87.9%, while in group 2 (without preparation) - 66.7%. Odds ratio calculation between the two groups revealed that preoperative preparation with the tear substitute Stillavit reduced the odds of IOP elevation to 20 mm Hg or higher at 3 months postoperatively by more than 10 times.

Conclusion: The use of tear substitute Stillavit in preparation for anti-glaucoma surgery reduces the chances of IOP elevation in the early postoperative period by more than 10 times, which may indicate a reduction in the rate of FB scarring due to the beneficial effect of the drug's components on the precorneal tear film.

目的:本研究探讨了使用三组分泪液替代物Stillavit进行术前准备对长期接受青光眼局部治疗的患者青光眼手术效果的影响:研究对象包括 63 名青光眼患者(63 只眼),其中女性 30 名(30 只眼),男性 33 名(33 只眼)。第 1 组包括 33 名患者(33 只眼睛),他们长期接受局部降压治疗,并使用防腐剂和泪液替代品斯蒂拉维特,每天 3 次,为期 1 个月,作为术前准备。第二组包括 30 名患者(30 只眼睛),他们接受类似的降压治疗,但术前未服用任何药物。所有患者在术前以及术后 1 周、1、3 和 6 个月都接受了全面的眼科检查,并使用 Visante 系统(卡尔蔡司医疗技术公司,德国)对滤过性眼泡(FB)进行了计算机断层扫描:结果:与术前接受泪液替代物Stillavit治疗的患者相比,未进行泪液替代物术前准备的患者在术后6个月的平均眼压升高明显更高。根据前段光学相干断层扫描结果,在准备手术时使用了泪液替代品斯蒂拉维特的组别中,有更多的弥漫性 FB 呈阳性,占 87.9%,而在第二组(未做准备)中,这一比例为 66.7%。两组之间的比值比计算显示,使用Stillavit泪液替代物进行术前准备可将术后3个月眼压升高至20毫米汞柱或更高的几率降低10倍以上:结论:在抗青光眼手术准备过程中使用泪液替代物 Stillavit 可将术后早期眼压升高的几率降低 10 倍以上,这可能表明由于药物成分对角膜前泪膜的有益作用,FB 结疤的发生率有所降低。
{"title":"[Three-component tear substitute as preoperative support in glaucoma surgery].","authors":"N V Makashova, A E Vasillyeva, O Yu Kolosova","doi":"10.17116/oftalma202414003151","DOIUrl":"https://doi.org/10.17116/oftalma202414003151","url":null,"abstract":"<p><strong>Purpose: </strong>This study investigates the effect of preoperative preparation with the three-component tear substitute Stillavit on the outcomes of glaucoma surgery in patients on long-term topical glaucoma therapy.</p><p><strong>Material and methods: </strong>The study included 63 patients (63 eyes) with glaucoma, among them 30 (30 eyes) were women and 33 (33 eyes) were men. Group 1 consisted of 33 patients (33 eyes) receiving long-term topical antihypertensive therapy with preservatives and tear substitute Stillavit 3 times a day for 1 month as preoperative preparation. Group 2 included 30 patients (30 eyes) receiving similar antihypertensive therapy who were not prescribed preoperative medications. All patients underwent a comprehensive ophthalmological examination and computer tomography of the filtering blebs (FB) on Visante system (Carl Zeiss Meditec, Germany) before surgery, as well as 1 week, 1, 3, and 6 months after surgery.</p><p><strong>Results: </strong>Mean intraocular pressure (IOP) elevation at 6 months postoperatively was significantly higher in the group that did not undergo preoperative preparation with a tear substitute, compared to the group of patients who received the tear substitute Stillavit preoperatively. According to anterior segment optical coherence tomography, a greater number of favorable diffuse FB were noted in the group that received the tear substitute Stillavit in preparation for surgery - 87.9%, while in group 2 (without preparation) - 66.7%. Odds ratio calculation between the two groups revealed that preoperative preparation with the tear substitute Stillavit reduced the odds of IOP elevation to 20 mm Hg or higher at 3 months postoperatively by more than 10 times.</p><p><strong>Conclusion: </strong>The use of tear substitute Stillavit in preparation for anti-glaucoma surgery reduces the chances of IOP elevation in the early postoperative period by more than 10 times, which may indicate a reduction in the rate of FB scarring due to the beneficial effect of the drug's components on the precorneal tear film.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"51-58"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of artificial intelligence in glaucoma. Part 1. Neural networks and deep learning in glaucoma screening and diagnosis]. [人工智能在青光眼中的应用。第一部分:神经网络和深度学习在青光眼筛查和诊断中的应用]。神经网络和深度学习在青光眼筛查和诊断中的应用]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414003182
N I Kurysheva, O Ye Rodionova, A L Pomerantsev, G A Sharova

This article reviews literature on the use of artificial intelligence (AI) for screening, diagnosis, monitoring and treatment of glaucoma. The first part of the review provides information how AI methods improve the effectiveness of glaucoma screening, presents the technologies using deep learning, including neural networks, for the analysis of big data obtained by methods of ocular imaging (fundus imaging, optical coherence tomography of the anterior and posterior eye segments, digital gonioscopy, ultrasound biomicroscopy, etc.), including a multimodal approach. The results found in the reviewed literature are contradictory, indicating that improvement of the AI models requires further research and a standardized approach. The use of neural networks for timely detection of glaucoma based on multimodal imaging will reduce the risk of blindness associated with glaucoma.

本文综述了有关将人工智能(AI)用于青光眼筛查、诊断、监测和治疗的文献。综述的第一部分介绍了人工智能方法如何提高青光眼筛查的有效性,介绍了利用深度学习(包括神经网络)分析眼部成像方法(眼底成像、前后眼球光学相干断层扫描、数字眼底镜检查、超声生物显微镜检查等)获得的大数据的技术,包括多模态方法。所查阅文献中发现的结果相互矛盾,这表明人工智能模型的改进需要进一步的研究和标准化的方法。使用神经网络根据多模态成像及时发现青光眼,将降低与青光眼相关的失明风险。
{"title":"[Application of artificial intelligence in glaucoma. Part 1. Neural networks and deep learning in glaucoma screening and diagnosis].","authors":"N I Kurysheva, O Ye Rodionova, A L Pomerantsev, G A Sharova","doi":"10.17116/oftalma202414003182","DOIUrl":"https://doi.org/10.17116/oftalma202414003182","url":null,"abstract":"<p><p>This article reviews literature on the use of artificial intelligence (AI) for screening, diagnosis, monitoring and treatment of glaucoma. The first part of the review provides information how AI methods improve the effectiveness of glaucoma screening, presents the technologies using deep learning, including neural networks, for the analysis of big data obtained by methods of ocular imaging (fundus imaging, optical coherence tomography of the anterior and posterior eye segments, digital gonioscopy, ultrasound biomicroscopy, etc.), including a multimodal approach. The results found in the reviewed literature are contradictory, indicating that improvement of the AI models requires further research and a standardized approach. The use of neural networks for timely detection of glaucoma based on multimodal imaging will reduce the risk of blindness associated with glaucoma.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"82-87"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[First experience of implantation of extended depth of focus intraocular lenses in patients with glaucoma]. [为青光眼患者植入延焦深度眼内透镜的首次经验]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414003170
N Yu Gorbunova, R A Yakovlev, N A Pozdeyeva, N O Mikhailov

Purpose: This study evaluates the effectiveness of implantation of extended depth of focus (EDOF) intraocular lenses (IOL) in patients with cataract and glaucoma.

Material and methods: The study included 13 patients (16 eyes) who underwent implantation of the Lentis Comfort EDOF IOL (Teleon Surgical BV, Netherlands). Standard phacoemulsification cataract surgery with IOL implantation was performed in a planned manner after the hypotensive surgery stage in two eyes; a combined procedure was performed in 14 cases. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), near visual acuity, and intraocular pressure (IOP) measured with a Maklakov tonometer were assessed preoperatively, on the first day, and 3-6 months after surgery. Computer perimetry using the 30-2 program and spatial contrast sensitivity (SCS) assessment were also performed preoperatively and at the same follow-up time points.

Results: On the first day after surgery, UCVA was 0.53±0.65, BCVA was 0.85±0.45. Near UCVA (at 40 cm) was 0.5±0.14 on the first day after surgery and 0.56±0.18 at 3-6 months. According to computer perimetry data, retinal light sensitivity values increased in all patients in the long-term (-3.1±2.9 dB). SCS values increased for objects of all sizes compared to preoperative values.

Conclusion: Implantation of EDOF IOL contributes to improved vision without reducing contrast sensitivity and retinal light sensitivity in patients with concomitant cataract and glaucoma.

目的:本研究评估了白内障和青光眼患者植入延焦深度(EDOF)眼内人工晶体(IOL)的效果:研究对象包括 13 名患者(16 只眼),他们都接受了 Lentis Comfort EDOF 人工晶体植入术(荷兰 Teleon Surgical BV 公司)。在两只眼睛的降压手术阶段后,按计划进行了标准白内障超声乳化手术和人工晶体植入术;14 例患者进行了联合手术。对术前、术后第一天和术后 3-6 个月的未矫正视力(UCVA)、最佳矫正视力(BCVA)、近视力和用马克拉科夫眼压计测量的眼压(IOP)进行了评估。在术前和相同的随访时间点,还使用 30-2 程序进行了计算机验光和空间对比敏感度(SCS)评估:术后第一天,UCVA 为 0.53±0.65,BCVA 为 0.85±0.45。术后第一天的近 UCVA(40 厘米处)为 0.5±0.14,3-6 个月时为 0.56±0.18。根据计算机测光数据,所有患者的视网膜光敏感度值在长期内都有所提高(-3.1±2.9 dB)。与术前相比,所有大小物体的 SCS 值均有所增加:结论:对同时患有白内障和青光眼的患者而言,植入 EDOF 人工晶体有助于改善视力,同时不会降低对比敏感度和视网膜光敏感度。
{"title":"[First experience of implantation of extended depth of focus intraocular lenses in patients with glaucoma].","authors":"N Yu Gorbunova, R A Yakovlev, N A Pozdeyeva, N O Mikhailov","doi":"10.17116/oftalma202414003170","DOIUrl":"https://doi.org/10.17116/oftalma202414003170","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates the effectiveness of implantation of extended depth of focus (EDOF) intraocular lenses (IOL) in patients with cataract and glaucoma.</p><p><strong>Material and methods: </strong>The study included 13 patients (16 eyes) who underwent implantation of the Lentis Comfort EDOF IOL (Teleon Surgical BV, Netherlands). Standard phacoemulsification cataract surgery with IOL implantation was performed in a planned manner after the hypotensive surgery stage in two eyes; a combined procedure was performed in 14 cases. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), near visual acuity, and intraocular pressure (IOP) measured with a Maklakov tonometer were assessed preoperatively, on the first day, and 3-6 months after surgery. Computer perimetry using the 30-2 program and spatial contrast sensitivity (SCS) assessment were also performed preoperatively and at the same follow-up time points.</p><p><strong>Results: </strong>On the first day after surgery, UCVA was 0.53±0.65, BCVA was 0.85±0.45. Near UCVA (at 40 cm) was 0.5±0.14 on the first day after surgery and 0.56±0.18 at 3-6 months. According to computer perimetry data, retinal light sensitivity values increased in all patients in the long-term (-3.1±2.9 dB). SCS values increased for objects of all sizes compared to preoperative values.</p><p><strong>Conclusion: </strong>Implantation of EDOF IOL contributes to improved vision without reducing contrast sensitivity and retinal light sensitivity in patients with concomitant cataract and glaucoma.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"70-74"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Risk factors associated with myopic maculopathy in acquired myopia]. [后天性近视中与近视性黄斑病变相关的风险因素]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414005135
O V Kolenko, L V Bushnina, I E Pashentsev, N V Pomytkina, E L Sorokin

Purpose: This study aimed to identify factors associated with the development of myopic maculopathy (MM) in patients with acquired myopia.

Material and methods: The study included a total of 135 patients (41 men, 94 women; 135 eyes) over 30 years old with acquired myopia and axial length (AL) of 26 mm. Forty-six patients had MM, while 89 (66%) had no macular changes. Optical coherence tomography angiography (OCT-A) and B-scan ultrasound of the eyes were performed to detect staphylomas of the posterior pole sclera. OCT was used to assess corneal stromal thickness and choroidal thickness. Corneal biomechanics were measured using the Corvis ST device, and ocular vessel hemodynamics were evaluated using color Doppler imaging. Binary logistic regression was employed, with a multivariable logistic model built for each of these potential risk factors, adjusted for sex, age, AL, and spherical equivalent (SE).

Results: Age, AL, SE, and extra-macular myopic changes were significantly associated with the presence of MM. Of the seven qualitative risk factors studied, the presence of extra-macular changes, staphyloma, and wide macular staphyloma localization were statistically significant. Among the quantitative factors, significant associations were found with the width and depth of staphyloma, the area of the ultrasound cross-section of staphyloma (W×D), choroidal thickness in all examined zones, all corneal stromal thickness parameters, corneal deformation amplitude (DA), curvature radius highest concavity (radius HC), and corneal peak distance (PD).

Conclusion: The statistically significant risk factors associated with MM were age, AL, SE, the presence and size of staphylomas, choroidal and corneal stromal thickness, as well as several parameters characterizing corneal biomechanical properties. The strongest associations with MM were found for corneal PD, staphyloma depth, and choroidal thickness in the nasal perifovea.

目的:本研究旨在确定后天性近视患者发生近视性黄斑病变(MM)的相关因素:研究共纳入 135 名年龄超过 30 岁的后天性近视患者(41 名男性,94 名女性;135 只眼睛),他们的轴长(AL)均为 26 毫米。46名患者患有黄斑病变,89名患者(66%)没有黄斑病变。为检测后极部巩膜葡萄状瘤,对患者的眼睛进行了光学相干断层血管造影(OCT-A)和 B 超扫描。光学相干断层扫描用于评估角膜基质厚度和脉络膜厚度。使用 Corvis ST 设备测量角膜生物力学,并使用彩色多普勒成像评估眼部血管血流动力学。采用二元逻辑回归法,针对每个潜在风险因素建立多变量逻辑模型,并对性别、年龄、AL和球面等值(SE)进行调整:结果:年龄、视力等效值、球面等效值和黄斑外近视变化与 MM 的存在有显著相关性。在所研究的七个定性风险因素中,黄斑外病变、葡萄胎瘤和宽黄斑葡萄胎瘤定位的存在具有统计学意义。在定量因素中,葡萄状瘤的宽度和深度、葡萄状瘤的超声截面面积(W×D)、所有检查区域的脉络膜厚度、所有角膜基质厚度参数、角膜变形幅度(DA)、曲率半径最高凹度(半径HC)和角膜峰值距离(PD)均有显著相关性:在统计学上,与MM相关的重要风险因素包括年龄、AL、SE、葡萄状瘤的存在和大小、脉络膜和角膜基质厚度,以及几个表征角膜生物力学特性的参数。角膜PD、葡萄状瘤深度和鼻眼周脉络膜厚度与MM的关联性最强。
{"title":"[Risk factors associated with myopic maculopathy in acquired myopia].","authors":"O V Kolenko, L V Bushnina, I E Pashentsev, N V Pomytkina, E L Sorokin","doi":"10.17116/oftalma202414005135","DOIUrl":"https://doi.org/10.17116/oftalma202414005135","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to identify factors associated with the development of myopic maculopathy (MM) in patients with acquired myopia.</p><p><strong>Material and methods: </strong>The study included a total of 135 patients (41 men, 94 women; 135 eyes) over 30 years old with acquired myopia and axial length (AL) of 26 mm. Forty-six patients had MM, while 89 (66%) had no macular changes. Optical coherence tomography angiography (OCT-A) and B-scan ultrasound of the eyes were performed to detect staphylomas of the posterior pole sclera. OCT was used to assess corneal stromal thickness and choroidal thickness. Corneal biomechanics were measured using the Corvis ST device, and ocular vessel hemodynamics were evaluated using color Doppler imaging. Binary logistic regression was employed, with a multivariable logistic model built for each of these potential risk factors, adjusted for sex, age, AL, and spherical equivalent (SE).</p><p><strong>Results: </strong>Age, AL, SE, and extra-macular myopic changes were significantly associated with the presence of MM. Of the seven qualitative risk factors studied, the presence of extra-macular changes, staphyloma, and wide macular staphyloma localization were statistically significant. Among the quantitative factors, significant associations were found with the width and depth of staphyloma, the area of the ultrasound cross-section of staphyloma (W×D), choroidal thickness in all examined zones, all corneal stromal thickness parameters, corneal deformation amplitude (DA), curvature radius highest concavity (radius HC), and corneal peak distance (PD).</p><p><strong>Conclusion: </strong>The statistically significant risk factors associated with MM were age, AL, SE, the presence and size of staphylomas, choroidal and corneal stromal thickness, as well as several parameters characterizing corneal biomechanical properties. The strongest associations with MM were found for corneal PD, staphyloma depth, and choroidal thickness in the nasal perifovea.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 5","pages":"35-45"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vestnik oftalmologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1